Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors
- 28 February 1995
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 172 (2) , 574-579
- https://doi.org/10.1016/0002-9378(95)90575-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: A Gynecologic Oncology Group StudyGynecologic Oncology, 1990
- Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumorsGynecologic Oncology, 1990
- The role of low‐dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT)BJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Treatment of nonmetastatic gestational trophoblastic disease with oral methotrexateAmerican Journal of Obstetrics and Gynecology, 1987
- Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic diseaseGynecologic Oncology, 1986
- Methotrexate with citrovorum factor rescue in gestational trophoblastic diseaseAmerican Journal of Obstetrics and Gynecology, 1985
- Treatment of nonmetastatic gestational trophoblastic disease: Results of methotrexate alone versus methotrexate-folinic acidAmerican Journal of Obstetrics and Gynecology, 1982
- The role of operation in the current therapy of gestational trophoblastic diseaseAmerican Journal of Obstetrics and Gynecology, 1980
- Risk and prognostic factors in trophoblastic neoplasiaCancer, 1976
- Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasmsAmerican Journal of Obstetrics and Gynecology, 1967